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Abstract
Background: The purpose of this article is to document the clinical features of the unusual
mitral valve myxoma based on the literature of recent years.
Methods: A literature retrieval of the mitral valve myxoma reported in recent years was made
using the MEDLINE and EMBASE databases. The clinical information about this unusual
disorder was collected and analyzed.
Results: Mitral valve myxoma showed female predilection. Their major symptoms were
cardiovascular or cerebrovascular, in addition to constitutional or embolic. The diagnosis was
usually made based on two- and three-dimensional transthoracic and/or transesophageal
echocardiography, as well as magnetic resonance imaging in the current era. Surgical resec-
tion with mitral valve defect repair was the commonest remedy for mitral valve myxoma when
mitral valve function could be preserved, and the mitral valve should be replaced when neces-
sary. Patients showed good response to surgical treatment during the follow-up of 17.0 ±
± 28.4 months after the operation.
Conclusions: Two- and three-dimensional echocardiography and magnetic resonance
imaging are the major diagnostic tools for the diagnosis of a cardiac myxoma. After diagnosis,
surgery should be performed urgently, in order to prevent complications such as embolic events
or obstruction of the mitral orifice. Due to the fact that myxomas can recur, regular, postopera-
tive cardiological control is mandatory. (Cardiol J 2012; 19, 1: 105–109)
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Introduction
Cardiac myxomas are the commonest primary
cardiac tumors, accounting for 50% of cases. Myxo-
ma is more frequent in females than in males [1].
Most cardiac myxomas arise from the fossa ovalis,
while those that originate from the heart valves are
uncommon [2]. The purpose of this article is to docu-
ment the clinical features of the unusual mitral
valve myxoma based on the literature of recent
years.
Methods
Literature about mitral valve myxomas since
2006 in the MEDLINE and EMBASE databases was
retrieved, and data were analyzed in terms of its
clinical manifestation, optimal diagnostic methodo-
logy, surgical approaches, and long term follow-up.
Mitral valve myxoma is defined as a myxoma
arising from the mitral leaflet, annulus, commissure,
junction area or subvalvular apparatus (chorda or
papillary muscle) with a stalk or presenting as
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a broad-based one. Those myxomas originating
from other locations of the left heart chamber, but
with adherence to the mitral valve or apparatus,
were excluded.
Data were expressed in mean ± standard
deviation and student t test was used to evaluate
intergroup differences. A p < 0.05 was considered
of statistical significance.
Results
In all, there were 55 patients with 64 mitral
myxomas as described in 42 articles published since
2006 [3–44]. Of the 55 patients whose sex was re-
corded, there were 12 males and 19 females, show-
ing female gender predominance. There was no sig-
nificant difference between male and female patients’
age (32.79 ± 22.39 years, 43.75 ± 18.73 years,
p = 0.1692).
The symptoms were cardiovascular in 36.7%
of patients, and cerebral in 30% of patients, consti-
tuting the two main presentations of mitral valve
myxoma. Some patients presented with constitu-
tional symptoms or emboli or were asymptomatic
(Table 1). One patient had a family history of myxo-
mas [28]. Heart murmur was recorded in nine pa-
tients: eight patients had an apical systolic murmur
and one patient had a diastolic murmur.
Transthoracic and/or transesophageal echocar-
diography has become the first choice of diagnosis
for cardiac myxomas. They were used in all 33 pa-
tients whose diagnostic methods were recorded.
A mitral valve myxoma can be a large mass [23],
pedunculated [21], non-pedunculated [27], sessile
[40], heterogeneous [6, 16], homogeneous echoge-
nic [40], multilobulated mobile [32], well-circum-
scribed [41], or irregular adherent [39]. The size,
exact location, and the relation of the mitral myxo-
ma to the mitral structures could be clearly visua-
lized, and the transvalvular pressure gradient could
be measured. A cardiac myxoma may be misdiag-
nosed by transthoracic echocardiography [19]. How-
ever, transthoracic and transesophageal echocardio-
graphy can complement the visualization of a mitral
valve myxoma. In two of the 33 patients, cardiac
magnetic resonance imaging was used as a supple-
mentary diagnostic tool for mitral valve myxoma.
In 18 patients, the hemodynamic status asso-
ciated with mitral valve myxoma was reported:
three (16.7%) patients did not have any hemody-
namic disorder, while the other 15 (83.3%) patients
did (Table 2).
Of the 64 mitral myxomas, 44 were solitary, and
the other 20, in 11 patients, were multiple cardiac
myxomas. The atrial side of the anterior mitral leaf-
let was the commonest location of mitral myxoma
of either multiple or solitary lesions (Table 3). The
mitral myxomas were 2.96 ± 1.58 cm in size. The
solitary tumors were 2.71± 1.38 cm, while the
multiple ones measured 3.32 ± 1.78 cm. No differ-
ence was found between the sizes of the two groups
(p = 0.2940). The mitral myxomas located on the
atrial side of the mitral leaflet measured 2.85 ±
± 1.61 cm, while those on the ventricular side were
2.88 ± 1.82 cm in size. There was no significant dif-
ference in the tumor size between the atrial and
ventricular side (p = 0.9783).
Of the mitral valve myxomas, 11 were pedicled
and six were sessile with a pedicled-to-sessile ra-
tio of 1.83:1.
Tumor resection was performed in 35 of 37 pa-
tients, and conservative treatment in only two pa-
tients (Table 4). Tumor resection was the common-
est method of surgical treatment, followed by mitral
valve replacement. Mitral valve defect repair was
done in five patients, and endoscopic and minimally
invasive approaches were attempted in one patient
each (Table 4). Surgical approaches were mentioned
in six cases: left atriotomy in three (50%), right
atriotomy plus septal route in two (33.3%), and
biatrial route in one (16.7%) patient, respectively.
Table 2. Hemodynamic disorders of 15 mitral
myxoma patients.
Hemodynamic disorder Cases (%)
LVOTO 5 (33.3)
Mitral regurgitation 5 (33.3)
Mitral stenosis 1 (6.7)
Mitral regurgitation + tricuspid 2 (13.3)
regurgitation
LVOTO + mitral regurgitation 1 (6.7)
LVOTO + mitral stenosis 1 (6.7)
LVOTO — left ventricular outflow tract obstruction
Table 1. The main symptoms of mitral valve
myxoma.
Symptom Cases (%)
Asymptomatic 3 (10)
Constitutional 4 (13.3)
Embolic 1 (3.3)
Cardiovascular 11 (36.7)
Cerebral 9 (30)
Cardiovascular and cerebral 2 (6.7)
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The patients were observed for 17.0 ± 28.4
months after the operation. Only three complica-
tions were found in the patient setting: (1) a 40 year-
-old male patient had right retinal artery occlusion
three weeks after the operation: he retained mild
neurological deficit three months later [12]; (2)
a saccular aneurysm of abdominal aorta in a 12 year-
-old girl three weeks after mitral myxoma resec-
tion: she underwent an emergent surgery, and was
doing well at six month follow-up [16]; and (3)
a 25 year-old female patient developed thrombotic
mitral valvular obstruction one year later: a re-re-
placement of the mitral valve was performed and
she was well at ten year follow-up [40].
Discussion
Heart myxomas are usually located in the atri-
al septum near the fossa ovalis or the heart walls
and tend to be larger in size, thereby obstructing
the valvular orifice, while those originating from the
heart valves are uncommon and small in size [2].
Like the patients with usual cardiac myxomas, the
clinical symptoms of mitral valve myxomas were
predominantly cardiovascular (chest discomfort,
nonspecific chest pain, shortness of breath, exer-
tional dyspnea, orthopnoea, and palpitation) and
cerebral (numbness, dysesthesia, hemiplegia, focal
seizure, coma, transient ischemic attack, and stroke),
and could be constitutional (fever, weight loss, night
sweat, cachexia, weakness, and fatigue), or embolic.
Some patients may have elevated erythrocyte sedi-
ementation rate, rheumatoid factor, and C-reactive
protein [16]. Apical systolic murmur could be audi-
ble in some patients. Patients with mitral myxoma
may be associated with infective endocarditis [14].
Due to the influence of the mitral myxomas on the
mitral orifice or other adjacent heart structures,
hemodynamic disorders including left ventricular
outflow tract obstruction, mitral valve stenosis or
mitral valve regurgitation may occur.
In the very early days, the diagnoses of heart
valve myxomas were always made incidentally at
autopsy. Later, the clinical diagnosis mainly relied
on surgical exploration or ventriculogram due to
the limits of contemporary diagnostic techniques
[2]. Nowadays, with the development of less and
non-invasive diagnostic tools, myxomas, including
valvular myxomas, can be easily visualized by two-
and three-dimensional echocardiography or mag-
netic resonance imaging [45]. Transthoracic and
transesophageal echocardiography can be insuffi-
cient in non-invasive imaging of a myxoma. Other
methods, such as real-time three-dimensional
Table 4. Management of the mitral valve myxoma.
Management Cases (%)
Tumor resection 15 (40.5)
Tumor shaved 2 (5.4)
Tumor resection + mitral valve 1 (2.7)
preservation
Tumor resection + mitral valve 5 (13.5)
defect repair
Tumor resection + mitral valve 1 (2.7)
defect repair (endoscopic)
Tumor resection + tricuspid 1 (2.7)
and mitral repair
Minimally invasive tumor resection 1 (2.7)
Mitral valve replacement 8 (21.6)
Tumor shaved + artificial chord 1 (2.7)
+ mitral ring insertion
Conservative treatment for 1 (2.7)
transient ischemic attack
Follow-up without surgery was decided 1 (2.7)
because of her young age, unaffected
mitral valve functions and possible risk
of early recurrent thoracotomy
Table 3. Sites of the mitral valve myxoma.
Site of mitral myxoma Cases (%)
Multiple: 20 (30.3)
a.aml 11 (55)
a.pml 1 (5)
v.aml 1 (5)
?.pml 1 (5)
v.aml + papillary muscle 1 (5)
+ interventricular septum
annulus 1 (5)
papillary muscle 4 (20)
Solitary: 44 (66.7)
a.aml 19 (43.2)
annulus 3 (6.8)
a.aml + annulus 2 (4.5)
a.mitral valve 1 (2.3)
a.chord 1 (2.3)
?.pml 1 (2.3)
v.aml 1 (2.3)
v.aml + papillary muscle 1 (2.3)
v.pml 1 (2.3)
v.pml + chord 1 (2.3)
v.pml + annulus 1 (2.3)
mitral valve 8 (18.1)
papillary muscle 2 (4.5)
junction 2 (4.5)
? — either atrial or ventricular side of the mitral valve; a — atrial side
of the mitral valve; aml — anterior mitral leaflet; pml — posterior
mitral leaflet; v — ventricular side of the mitral valve
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echocardiography or magnetic resonance imaging,
should be used as complementary techniques
to evaluate intracardiac tumors with congenital
cardiac abnormalities before any cardiac surgery
treatment [46].
Recurrence rates reported for cardiac myxo-
mas are 4–7% for sporadic cases and 10–21% for
familial cases. Although recurrence rates are high,
second recurrences are rare [28].
After diagnosis, surgery should be performed
urgently, in order to prevent complications such as
embolic events or obstruction of the mitral orifice.
Follow-up examination, including echocardio-
graphy, should be performed regularly [1].
Tumor resection is the commonest surgical
treatment of mitral valve myxoma. Mitral valve
defect repair or annuloplasty are sometimes ne-
cessary in patients whose mitral functions are nor-
mal. In those patients whose mitral leaflet cannot
be preserved, the mitral valve should be replaced.
With the development of minimally invasive surgi-
cal techniques, mitral valve myxoma can be resect-
ed endoscopically with small incisions.
Conclusions
In conclusion, two- and three-dimensional
echocardiography and magnetic resonance imaging
are the major diagnostic tools for the diagnosis of
a cardiac myxoma. After diagnosis, surgery should
be performed urgently, in order to prevent compli-
cations such as embolic events or obstruction of the
mitral orifice. Due to the fact that myxomas can
recur, regular, postoperative cardiological control
is mandatory.
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